- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.10. | Everest Medicines Appoints Two to Strengthen Global mRNA R&D Capabilities | ||
| 09.10. | Chai Discovery, GSK Announce Collaboration Following Wet-Lab Evaluation | ||
| 09.10. | Lonza, Onava Strike AI Biologics Pact to Speed Drug Discovery | ||
| 09.10. | Tetrapharm Appoints Rolf Sass Soerensen as CEO | ||
| 09.10. | Viatris to Acquire Pacira in $1.65 Billion Deal | ||
| 09.10. | Bespak Secures Exclusive Access to SNBL Nasal Device | ||
| 08.10. | Biohaven, Ono Pharma Partner to Commercialize IgG Degrader for Graves' Disease | ||
| 08.10. | Bio-Techne Opens GMP-Grade Small-Molecule Manufacturing Facility in Bristol, UK | ||
| 08.10. | Pfizer Tukysa Regimen Gets FDA Nod for Maintenance Treatment of HER2+ Metastatic Breast Cancer | ||
| 08.10. | Andelyn Biosciences, PQP Partner to Streamline EU and UK Supply for CGT Sponsors | ||
| 08.10. | Ritedose Opens New $17M cGMP Laboratory | ||
| 07.10. | AmyriAD Therapeutics Acquires Recognify Life Sciences | ||
| 07.10. | Abionyx, Olon Partner to Develop and Commercialize Sepsis Treatment | ||
| 07.10. | Vir Biotechnology Taps Dr. David Liu as EVP and Chief Medical Officer | ||
| 07.10. | 10x Genomics Launches Multi-Project Collaboration with Fred Hutch Cancer Center | ||
| 07.10. | Piramal Pharma Opens New Microbiology Lab in Kentucky | ||
| 07.10. | Shionogi to Acquire IntraBio, Adding Aqneursa to Rare Disease Portfolio | ||
| 07.10. | Halozyme Wins Keytruda SC Patent Ruling | ||
| 07.10. | Alvotech, LOTTE Biologics Forge Strategic Biosimilars Manufacturing Pact | ||
| 07.10. | Bayer to Invest $2.2 Billion in New Ohio Pharma Manufacturing Site | ||
| 07.10. | Ofichem Acquires Kinentia Biosciences to Expand U.S. CDMO Presence | ||
| 06.10. | AstraZeneca Opens Strategic R&D Center in Massachusetts | ||
| 06.10. | Repligen Completes BioLife Solutions Acquisition | ||
| 06.10. | Terumo Launches K-Pack Embrace Safety Needle | ||
| 06.10. | Cognizant Extends Gilead Partnership for Five Years, Will Apply AI to DevOps |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.